Objective: The respiratory ratio is a dimensional construct of the respiratory subtype of panic disorder (PD). The respiratory subtype has been correlated with an increased sensitivity to CO 2 inhalation, positive family history of PD and low comorbidity with depression. The objective of our study was to determine whether the respiratory ratio is correlated with CO 2 -induced panic attacks and other clinical and demographic features. Methods: We examined 91 patients with PD and submitted them to a double-breath 35% CO 2 challenge test. The respiratory ratio was calculated based on the Diagnostic Symptom Questionnaire (DSQ) scores recorded in a diary in the days preceding the CO 2 challenge. The scores of the respiratory symptoms were summed and divided by the total DSQ score. Results: The respiratory ratio was correlated with CO 2 sensitivity, and there was a non-statistically significant trend towards a correlation with a family history of PD. Conclusions: The positive correlation between the respiratory ratio and the anxiety elicited by the CO 2 inhalation indicates that the intensity of respiratory symptoms may be proportional to the sensitivity to carbon dioxide.
Introduction
According to the DSM-IV, 1 panic disorder (PD) is a unitary diagnostic category. Nevertheless, within this category, there are diverse clinical presentations, leading to concerns that PD is not a singular diagnosis. 2 As a response to these concerns, alternative classification schemes have been devised. 2 Authors have proposed that the subtypes should be defined by the most prominent symptoms during a typical panic attack (PA), such as respiratory, cardiovascular, and gastrointestinal subtypes. 3 Respiratory abnormalities, such as increased sensitivity to CO 2 , are associated with PD, and there may be a connection between the respiratory subtype of PD and these abnormalities. 4 ,5 Klein 6 proposed that spontaneous PAs occur when the brain's suffocation monitor erroneously signals a lack of useful air, maladaptively triggering an evolved suffocation alarm system. Such a dysfunction would make an individual vulnerable to "false suffocation alarms", namely, PAs. Respiratory tests have been fruitful in generating hypotheses about PD, 6, 7 indicating that CO 2 sensitivity may be part of a hypersensitive suffocation detector. 6 PD patients exhibit both behaviorally and physiologically abnormal responses to respiratory challenge tests. 8, 9 The CO 2 inhalation increases pCO 2 and reduces pH in the blood, changes that are also observed in the brain. 10 Some regions of the brain that are sensitive to H+/CO 2 have been implicated in both ventilation control and defensive behaviors, including panic. The increase of CO 2 and H+ in the brain may activate these structures, inducing PAs and increasing ventilation. 10 The administration of 1 or 2 vital capacity breaths of a 35% CO 2 /65% O 2 mixture to patients with PD is a brief but intense stimulation, accompanied by neurovegetative symptoms similar to real-life PA symptomatology. 11, 12 These respiratory tests induce dose-dependent anxiety and panic symptoms in many subjects with and without PD, 10, 13, 14 but in PD patients, this response is significantly more intense.
11,12,15
In addition, healthy first-degree relatives of PD patients react significantly more to CO 2 inhalations than do healthy subjects without a family history of PD. 16 The research on CO 2 challenge tests strongly suggests a relationship between the pathophysiology of PD and some disturbance in breathing control. 4, 11 Recent studies indicate that patients with the respiratory subtype of PD are more sensitive to 35% CO 2 challenge tests and hyperventilation tests than subjects without this subtype. [17] [18] [19] Hypersensitivity to CO 2 and prominent respiratory symptoms might be markers for genetic vulnerability to respiratory PD. 5, 16 Briggs et al. 20 defined the respiratory subtype of PD as a distinct subgroup of PD patients with prominent respiratory symptoms. Respiratory subtype patients are more likely to have a family history of PD and exhibit low comorbidity with depression, longer illness duration and low neuroticism scores. 5 These patients also exhibit higher scores on PD severity scales, and the improvement with pharmacological treatment is observed more quickly than in patients without this subtype. 20, 21 Controversial findings also exist regarding the respiratory subtype, such as the correlation with the age of onset, tobacco and alcohol use. 5 A principal component analysis with PD symptoms conducted by Briggs et al. 20 determined that the presence of the fear of dying, chest pain/discomfort, shortness of breath, paresthesias, and feelings of choking during a PA defined a distinct subgroup of PD patients. If at least four of the five respiratory symptoms were present in a given patient, he or she was considered to have the respiratory subtype. 20 Throughout the years, many studies [17] [18] [19] [21] [22] [23] have been based on Briggs's classification, but none of the studies addressed two important problems: the classification does not account for the intensity of the respiratory and non-respiratory symptoms; and patients with many symptoms have an increased chance to be classified with the respiratory subtype. With Briggs' classification, patients with marked gastrointestinal or neurologic symptoms may report mild respiratory symptoms and be incorrectly classified in the respiratory subtype. On the other hand, if a patient has strong feelings of choking, shortness of breath and chest discomfort but does not experience paresthesias and fear of dying, he will not be diagnosed with the respiratory subtype. A method that accounted for the intensity of symptoms would lead to a more reliable classification of patient samples. Consistent findings are reported in patients with the respiratory subtype, such as a positive family history and high sensitivity to CO 2 challenge tests. 18, 19, 23 However, PD studies report conflicting findings regarding the age of onset and comorbidities. 24 These inconsistencies may be due to the limitations of the Briggs' classification.
The prevailing systems of classification of psychiatric disorders assume that the categorical representation is appropriate; disorders are laid out as distinct types and diagnosed as present or absent. However, some authors propose that dimensional taxonomy should be used in at least some conditions. 25 Studies indicate that dimensional constructs may be superior to categorical classifications because in addition to capturing the core symptoms, dimensional constructs capture the subtle psychopathology of anxiety disorders. 25, 26 Dimensional variation exists between and within categories, and quantitative variation can be simplified into categorical distinctions, 25 such as the respiratory subtype. In the current study, we defined the respiratory ratio, a dimensional correlate of the respiratory subtype, as the ratio between the respiratory and the non-respiratory symptoms occurring during PA, accounting for the intensity of each symptom. We hypothesize that the respiratory ratio is correlated with high sensitivity to CO 2 challenges, positive family history of PD and a low prevalence of major depression. The objective of this study was to ascertain whether the respiratory ratio can predict CO 2 -induced PAs and whether the respiratory ratio is correlated with specific clinical and demographic features in PD patients. This study is the first attempt to build a body of evidence concerning the respiratory ratio.
Methods

Subjects
In the current study, a database from a previous research project 27 was used. Patients with a diagnosis of PD with agoraphobia were consecutively recruited as they presented to the Laboratory of Panic and Respiration at the Institute of Psychiatry of the Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. The data collection for the original study lasted for approximately six months. After subjects received a clinical diagnosis of PD, made by an expert psychiatrist, they were interviewed by a second psychiatrist with the Structured Clinical Interview Diagnostic 28 for DSM-IV. 1 If the two clinicians disagreed on the diagnosis, they met to confer. If a consensus on the diagnosis could not be reached, the subject was not enrolled. Patients who met the DSM-IV criteria for current major depression, bipolar disorder, obsessive-compulsive disorder, schizophrenia, delusional or psychotic disorders, organic brain syndrome, severe personality disorder, suicide risk, epilepsy, or substance abuse or dependence (during the previous year) were excluded. Patients with comorbid dysthymia, generalized anxiety disorder, or past major depression were included if PD was judged to be the principal diagnosis. The protocol was explained to the subjects, who signed a voluntary written consent form to participate in the study. The subjects were informed that the procedure was not dangerous, but that anxiety symptoms could occur during the test. Our local ethics committee approved the protocol (approval number CAAE-0008.0.249.000-05, 14/2005), which complied with the principles of the Declaration of Helsinki. The inclusion criteria selected 18 to 55 years of age; both genders; occurrence of at least three PAs in the two weeks before the challenge test day and no use of any psychotropic drugs for at least one week by any subject. Exclusion criteria included unstable medical condition; cognitive-behavior psychotherapy during the study; use of any regular antipsychotic, antidepressant, regular benzodiazepine or non-benzodiazepine anxiolytic medication for four weeks before the use, the use of fluoxetine for five weeks before the test or a positive urine test for benzodiazepines or other drugs before the test. Subjects with a history of respiratory disease and smokers were also excluded. All subjects underwent a physical examination and laboratory examinations to ensure that they were healthy enough to participate in a CO 2 challenge test. The patients had no respiratory or cardiovascular abnormalities and were free of caffeine ingestion for one day. All subjects filled out a form with sociodemographic and clinical data, including age, gender, education, occupation, marital status, family history of PD and age of onset of PD. The family members were not examined.
Measures
The Subjective Units of Disturbance Scale (SUDS) is a quantitative evaluation method ranging from 0 (no anxiety) to 10 (maximum anxiety). 29 The Diagnostic Symptom Questionnaire (DSQ) is a list of 13 PA symptoms adapted from DSM-IV1 in which the presence and level of discomfort of each panic symptom experienced after the inhalations is rated on a 0-(none) to 4-point (very severe) scale, and the total score ranges from 0 to 52. 30 Both the SUDS and DSQ were used in the CO 2 inhalation procedure. To avoid baseline interference in the quantitative assessment of the SUDS measurements, the percentage of maximum increase or decrease possible in the SUDS score (PMIDPSUDS) was calculated. 31 The ΔSUDS was calculated as the difference between the SUDS score after the CO 2 inhalation (SUDS2) and the SUDS score before the inhalation (SUDS1). If the ΔSUDS was negative, the PMIDPSUDS was equal to the ΔSUDS divided by SUDS1.
If the ΔSUDS was positive, the PMIDPSUDS was equal to the ΔSUDS divided by the difference between the maximum SUDS score (10) and SUDS1. 31 During this first visit to our research center, each patient received a diary in which they recorded any PAs that occurred between the screen visit and the visit for the CO 2 test one week after. The respiratory ratio was calculated based on the DSQ scores of non-induced PAs registered in the diary. The scores of the respiratory symptoms (fear of dying, chest pain/discomfort, shortness of breath, paresthesias, and feelings of choking) were summed and divided by the total DSQ score for each patient.
Procedure
Before the inhalations, all subjects were asked to relax for 10 minutes. Respiratory frequency, pulse, and blood pressure were checked, and the measurements were repeated 1 and 5 minutes after the test. Using a double-blind (patient and medical raters) design setup, the patients inhaled the 35% CO 2 mixture or atmospheric compressed air, randomly selected with a coin flip by an independent staff member. The same test procedure was repeated after 20 minutes using other gas (i.e., 35% CO 2 or compressed air). During the test procedure, the patients exhaled as fully as possible, placed the inhalation mask, took a fast vital capacity breath, held their breath for 8 seconds, exhaled, and repeated the fast vital capacity breath, again holding for 8 seconds. The compliance with the tests was established by the three members of our team who attended present during the tests. Both tests were attended by one medical staff member who dealt with the patient and the gases (independent staff member) and by two test-blind rater psychiatrists. To measure the anxiety level before and after the CO 2 inhalation, we asked the subjects to complete the SUDS. The DSQ was also completed after the respiratory challenge.
Based on the DSQ, a CO 2 -induced PA was defined as the following: (1) the presence of 4 or more DSM-IV PA symptoms, where either the presence or the increase in DSM-IV symptomatology was used for diagnosis; (2) at least one DSM-IV cognitive panic symptom, that is, fear of dying, losing control, or going crazy; (3) the patient's statement that the sensation of panic or fear after the test resembled a spontaneous PA; and (4) an agreement of 2 medical doctors blind to whether the patient was receiving CO 2 or compressed air that the patient had a clinical PA. The SUDS scores were not used for diagnosing a PA. All of these criteria were used in the diagnosis of a PA to increase the reliability and clinical significance.
Statistical analysis
To calculate the correlations between the respiratory ratio and the other variables, the authors used the Pearson Correlation Coefficient for continuous variables with normal distributions, the Spearman's Rank Correlation Coefficient for ordinal variables and continuous variables without normal distributions and the Point-Biserial Correlation (PBC) to correlate continuous and dichotomous variables. The PBC is a special case of the Pearson Correlation Coefficient in which a continuous variable is correlated with a true dichotomy. The correlation coefficients were considered small when approximately .10, medium when .30 and large when .50. 32 The patients who suffered PAs after the CO 2 inhalation exhibited significantly higher respiratory ratios. The responders were significantly more likely to exhibit a family history of PD, a lower age of onset and a higher prevalence of previous major depression episodes. As expected, the SUDS2, PMIDPSUDS and DSQ were significantly higher for the responders compared to the non-responders. There were no differences in sex, age, education, marital status, or occupation between the groups (Table 2) .
To determine how well the respiratory ratio could predict CO 2 -induced Pas, the ROC curve was calculated. The area under the curve (AUC) was .707, and the respiratory ratio cutoff was .437. Using this cutoff, the sensitivity was 67.7%, the specificity was 65.5%, the positive predictive value was 80.8% and the negative predictive value was 48.7%.
Discussion
The respiratory ratio was correlated with CO 2 sensitivity. A non-statistically significant trend towards a correlation between the respiratory ratio and a family history of PD was observed. A positive family history of PD, comorbidity with major depression and an early age of onset were correlated with the response to carbon dioxide inhalation.
In the current study, prominent respiratory symptoms were correlated with a high sensitivity to CO 2 , consistent with the findings of previous studies. 17, 18, 27 Biber and Alkin 17 observed that 35% CO 2 inhalation induced PAs in 79% of patients with the respiratory subtype, whereas only 48% of patients with the non-respiratory subtype suffered PAs during the respiratory challenge. Valenca et al. 18 observed that 93.7% of patients with the respiratory subtype suffered PAs during 35% CO 2 inhalation, whereas only 43.4% of patients with the non-respiratory subtype suffered PAs, indicating a higher sensitivity to CO 2 in patients with the respiratory subtype. In a study using a 5% CO 2 rebreathing challenge, 22 more respiratory subtype patients than non-respiratory subtype patients terminated the procedure voluntarily. Respiratory subtype patients also exhibited a higher respiratory frequency and more suffocation sensations than non-respiratory subtype patients. 22 The intensity of respiratory symptoms in PD patients may be proportional to the sensitivity to CO 2 , and a slight increase in CO 2 levels might be misinterpreted as a lack of useful air, triggering PD symptoms.
Another interesting finding from the current study is that the responders exhibited a higher family prevalence of PD than did the non-responders. Perna et al. 16 described the treatment-seeking PD probands, their first-degree relatives, and the relatives of normal controls. Although relatives with a personal history of any mental disorder were excluded, 22% of those related to PD probands developed a PA after one inhalation of 35% CO 2 . Fifty-one percent of the PD probands but only 2% of the relatives of normal controls developed PAs as well. Thus, high-risk relatives were significantly less likely to develop PAs with CO 2 than were ill probands. 16 In a similar study, 44% of the first-degree relatives of PD patients exhibited PAs after one inhalation of 35% CO 2 , whereas only 12% of the controls exhibited PAs. 33 Bellodi et al. 34 conducted a twin study that generated strong evidence for the role of genetic factors in the sensitivity to CO 2 inhalation. If it could Responders and non-responders to the CO 2 challenge were compared with respect to their respiratory ratio and demographic and clinical features. The Student's t-test was used to compare the means of numeric variables between the two groups, and the chi-square test was used to compare categorical variables.
To ascertain the predictive value of the respiratory ratio, the ROC curve was analyzed. A respiratory ratio cutoff was defined based on the smallest difference between the sensitivity and specificity values. The positive predictive value and negative predictive value were calculated.
All analyses were two-tailed, and the level of statistical significance was set at 5%.
Results
A sample of 91 patients with PD was included in the trial. A total of 62 patients with PD (68.1%) suffered a PA after the CO 2 test (responders), and 29 patients with PD (31.9%) did not suffer a PA after the test (non-responders).
In our sample, we did not reject the normality hypothesis of the respiratory ratio (Kolmogorov Smirnov Z, p = .872), and the mean was .458 (SD = .104), indicating that the respiratory symptoms represented approximately 45.8% of the PD symptoms registered in the diary of all patients. The respiratory ratio exhibited moderate positive correlations with PMIDPSUDS and the response to CO 2 inhalation. We also observed trends towards positive correlations with SUDS2 and family history and a negative correlation with education ( Table 1) .
The hypothesis of normality was rejected for PMIDPSUDS (Kolmogorov Smirnov Z, p = .003) and SUDS2 (Kolmogorov Smirnov Z, p < .001), and linear regression based on normality was not possible using these variables. Although it would have been possible to use a nonparametric regression, it would have been difficult for psychiatrists to read. We decided not to base our conclusions on linear regressions. be established that an abnormal sensitivity to CO 2 comprises a marker for PD, the test could be used to identify individuals with a relatively high risk for the onset of spontaneous PAs. Although the current study failed to demonstrate a strong association between the respiratory ratio and a family history of PD, there is evidence in the literature of an association between genetics and respiratory symptoms. Studies indicate that 62.1% to 71.4% of PD patients with the respiratory subtype have a family history of PD, whereas only 31.3% to 37.9% of patients without the respiratory subtype have a first-degree relative with this disorder. 19, 23, 27 Studies of the genetics of PD suggest that the respiratory subtype may be an important biological marker, although none of these studies have addressed this question directly. 5 In the current study, the correlation between the respiratory ratio and a family history of PD did not reach statistical significance, but future studies, with larger samples, may identify this association.
The main limitations of this study were the small sample size and the lack of equipment to confirm that the subjects inhaled full vital capacities of 35% CO 2 and air during the experiment.
Conclusion
The positive correlation between the respiratory ratio and the PD symptoms elicited by the CO 2 inhalation indicate that the intensity of respiratory symptoms may be commensurable with the sensitivity to carbon dioxide. The respiratory ratio may be a useful tool in the research of PD as a bridge connecting the psychopathology to the underlying neurobiology. 
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